Market Cap | 225.66M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.11M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 127.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 126.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -10.00% |
Recommedations | - | Quick Ratio | 0.13 | Shares Outstanding | 8.09M | 52W Low Chg | 818.00% |
Insider Own | 3.57% | ROA | - | Shares Float | 5.30M | Beta | - |
Inst Own | 91.20% | ROE | - | Shares Shorted/Prior | 4.18K/7.90K | Price | 22.50 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 26,506 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 122,046 | Change | 132.68% |
Larkspur Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the biotechnology sector in the United States. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.